The Application Of Radiomics And Artificial Intelligence In Cancer Imaging

The rapid development of artificial intelligence technology in medical data analysis has led to the concept of radiomics. This book introduces the essential and latest technologies in radiomics, such as imaging segmentation, quantitative imaging feature extraction, and machine learning methods for model construction and performance evaluation, providing invaluable guidance for the researcher entering the field. It fully describes three key aspects of radiomic clinical practice: precision diagnosis, the therapeutic effect, and prognostic evaluation, which make radiomics a powerful tool in the clinical setting. This book is a very useful resource for scientists and computer engineers in machine learning and medical image analysis, scientists focusing on antineoplastic drugs, and radiologists, pathologists, oncologists, as well as surgeons wanting to understand radiomics and its potential in clinical practice. An introduction to the concepts of radiomics In-depth presentation of the core technologies and methods Summary of current radiomics research, perspective on the future of radiomics and the challenges ahead An introduction to several platforms that are planned to be built: cooperation, data sharing, software, and application platforms

The clinical use of Artificial Intelligence (AI) in radiation oncology is in its infancy. However, it is certain that AI is capable of making radiation oncology more precise and personalized with improved outcomes. Radiation oncology deploys an array of state-of-the-art technologies for imaging, treatment, planning, simulation, targeting, and quality assurance while managing the massive amount of data involving therapists, dosimetrists, physicists, nurses, technologists, and managers. AI consists of many powerful tools which can process a huge amount of inter-related data to improve accuracy, productivity, and automation in complex operations such as radiation oncology.This book offers an array of AI scientific concepts, and AI technology tools with selected examples of current applications to serve as a one-stop AI resource for the radiation oncology community. The clinical adoption, beyond research, will require ethical considerations and a framework for an overall assessment of AI as a set of powerful tools.30 renowned experts contributed to sixteen chapters organized into six sections: Define the Future, Strategy, AI Tools, AI Applications, and Assessment and Outcomes. The future is defined from a clinical and a technical perspective and the strategy discusses lessons learned from radiology experience in AI and the role of open access data to enhance the performance of AI tools. The AI tools include radiomics, segmentation, knowledge representation, and natural language processing. The AI applications discuss knowledge-based treatment planning and automation, AI-based treatment planning, prediction of radiotherapy toxicity, radiomics in cancer prognostication and treatment response, and the use of AI for mitigation of error propagation. The sixth section elucidates two critical issues in the clinical adoption: ethical issues and the evaluation of AI as a transformative technology.

Radiomics and Radiogenomics: Technical Basis and Clinical Applications provides a first summary of the overlapping fields of radiomics and radiogenomics, showcasing how they are being used to evaluate disease characteristics and correlate with treatment response and patient prognosis. It explains the fundamental principles, technical bases, and clinical applications with a focus on oncology. The book’s expert authors present computational approaches for extracting imaging features that help to detect and characterize disease tissues for improving diagnosis, prognosis, and evaluation of therapy response. This book is intended for audiences including imaging scientists, medical physicists, as well as medical professionals and specialists such as diagnostic radiologists, radiation oncologists, and medical oncologists. Features Provides a first complete overview of the technical underpinnings and clinical applications of radiomics and radiogenomics Shows how they are improving diagnostic and prognostic decisions with greater efficacy Discusses the image informatics, quantitative imaging, feature extraction, predictive modeling, software tools, and other key areas Covers applications in oncology and beyond, covering all major disease sites in separate chapters Includes an introduction to basic principles and discussion of emerging research directions with a roadmap to clinical translation

Big Data in Radiation Oncology gives readers an in-depth look into how big data is having an impact on the clinical care of cancer patients. While basic principles and key analytical and processing techniques are introduced in the early chapters, the rest of the book turns to clinical applications, in particular for cancer registries, informatics, radiomics, radiogenomics, patient safety and quality of care, patient-reported outcomes, comparative effectiveness, treatment planning, and clinical decision-making. More features of the book are: Offers the first focused treatment of the role of big data in the clinic and its impact on radiation therapy. Covers applications in cancer registry, radiomics, patient safety, quality of care, treatment planning, decision making, and other key areas. Discusses the fundamental principles and techniques for processing and analysis of big data. Address the use of big data in cancer prevention, detection, prognosis, and management. Provides practical guidance on implementation for clinicians and other stakeholders. Dr. Jun Deng is a professor at the Department of Therapeutic Radiology of Yale University School of Medicine and an ABR board certified medical physicist at Yale-New Haven Hospital. He has received numerous honors and awards such as Fellow of Institute of Physics in 2004, AAPM Medical Physics Travel Grant in 2008, ASTRO IGRT Symposium Travel Grant in 2009, AAPM-IPEM Medical Physics Travel Grant in 2011, and Fellow of AAPM in 2013. Lei Xing, Ph.D., is the Jacob Haimson Professor of Medical Physics and Director of Medical Physics Division of Radiation Oncology Department at Stanford University. His research has been focused on inverse treatment planning, tomographic image reconstruction, CT, optical and PET imaging instrumentations, image guided interventions, nanomedicine, and applications of molecular imaging in radiation oncology. Dr. Xing is on the editorial boards of a number of journals in radiation physics and medical imaging, and is recipient of numerous awards, including the American Cancer Society Research Scholar Award, The Whitaker Foundation Grant Award, and a Max Planck Institute Fellowship.